Viewing Study NCT02335268


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-02-22 @ 12:23 PM
Study NCT ID: NCT02335268
Status: COMPLETED
Last Update Posted: 2023-08-16
First Post: 2015-01-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia
Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS classified as IPSS low/int-1 View